SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma

scientific article published on 25 August 2020

SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TRANSCI.2020.102922
P932PMC publication ID7446657
P698PubMed publication ID32883593

P50authorErnst J. SchaeferQ124678742
P2093author name stringLisa Cook
Margaret R Diffenderfer
Danyal Ibrahim
Steven B Kleiboeker
Dorothy B Wakefield
Syed A Hussain
Rebecca Crowell
Kendra Williams
Jessica McKenzie
Latha Dulipsingh
Jennifer Puff
Patricia Nabors
Colleen Lima
Mary Onoroski
Reginald J Eadie
P2860cites workThe effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysisQ27001157
Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.Q30398715
Use of convalescent plasma therapy in SARS patients in Hong KongQ47875099
Treatment of severe acute respiratory syndrome with convalescent plasma.Q51660103
Treatment with convalescent plasma for influenza A (H5N1) infectionQ81391936
Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2Q87726414
Virological assessment of hospitalized patients with COVID-2019Q89379643
The convalescent sera option for containing COVID-19Q90296531
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyQ90658465
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent PlasmaQ90702138
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoVQ90713511
Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected PatientsQ90714901
Clinical and virological data of the first cases of COVID-19 in Europe: a case seriesQ90732490
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and howQ91510657
Treatment With Convalescent Plasma for Critically Ill Patients With SARS-CoV-2 InfectionQ91537559
Effectiveness of convalescent plasma therapy in severe COVID-19 patientsQ91611037
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019Q91660911
Detection of serum IgM and IgG for COVID-19 diagnosisQ91748689
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in KoreaQ91849623
Treatment with convalescent plasma for COVID-19 patients in Wuhan, ChinaQ91952878
Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patientsQ92013616
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort studyQ92128365
Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19Q93150027
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsQ96577059
Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donationQ97079201
Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapyQ97438796
The Emerging Role of Convalescent Plasma in the Treatment of COVID-19Q97545650
Associations between blood type and COVID-19 infection, intubation, and deathQ102058933
P921main subjectvirologyQ7215
SARS-CoV-2Q82069695
convalescent plasmaQ105209484
P304page(s)102922
P577publication date2020-08-25
P1433published inTransfusion and Apheresis ScienceQ15758507
P1476titleSARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma

Search more.